A novel approach for emerging and antibiotic resistant infections: Innate defense regulators as an agnostic therapy
Authors:
Open Access
- 1 May 2016
- journal article
- research article
- Published by Elsevier in Journal of Biotechnology
- Vol. 226, 24-34
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Regulation of MyD88 Aggregation and the MyD88-dependent Signaling Pathway by Sequestosome 1 and Histone Deacetylase 6Journal of Biological Chemistry, 2010
- New thoughts on the initiation of mucositisOral Diseases, 2010
- The Sequestosome 1/p62 Attenuates Cytokine Gene Expression in Activated Macrophages by Inhibiting IFN Regulatory Factor 8 and TNF Receptor-Associated Factor 6/NF-κB ActivityThe Journal of Immunology, 2009
- Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responsesNature Reviews Immunology, 2004
- Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteriaProceedings of the National Academy of Sciences, 2004
- Innate Immune RecognitionAnnual Review of Immunology, 2002
- Tumour necrosis factor alpha and its soluble receptors in juvenile chronic arthritisRheumatology, 2000
- Physiologic role of interleukin-1 receptor antagonistArthritis Research & Therapy, 2000
- The proinflammatory cytokine network: interactions in the CNS and blood of rhesus monkeysAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 1998
- ROLE OF CYTOKINES IN RHEUMATOID ARTHRITISAnnual Review of Immunology, 1996